RYPLAZIM
STN: 125659
Proper Name: plasminogen, human-tvmh
Tradename: RYPLAZIM
Manufacturer: Prometic Biotherapeutics Inc.
Indication:
- For the treatment of patients with plasminogen deficiency type 1 (hypoplasminogenemia)
Product Information
- Package Insert - RYPLAZIM
- Demographic Subgroup Information – plasminogen, human-tvmh
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.